Diagnos Inc (TSE:ADK) has released an update.
Diagnos Inc. is set to showcase trailblazing artificial intelligence technologies for retinal health at the ARVO 2024 Annual Meeting, highlighting advancements in early detection and diagnosis of retinal diseases. Their AI models demonstrate significant accuracy in identifying diseases through retinal imaging, with the potential to prevent vision loss. The company’s innovations cover AI-assisted screening, hypertensive retinopathy detection, and diabetic retinopathy grading, underscoring their role at the cutting edge of AI in healthcare.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.
